Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Condition(s):Choroidal Neovascularization; Myopia, DegenerativeLast Updated:November 1, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Choroidal Neovascularization; Myopia, DegenerativeLast Updated:November 1, 2011Completed
Condition(s):Cancer; TumorLast Updated:November 1, 2011Completed
Condition(s):Neoplasm MetastasisLast Updated:August 23, 2011Completed
Condition(s):Head and Neck CancerLast Updated:June 11, 2010Completed
Condition(s):Combretastatin A4 Phosphate; Age-related Macular Degeneration; AMD; CNV; Choroidal NeovascularizationLast Updated:December 6, 2017Completed
Condition(s):TumorsLast Updated:October 31, 2011Completed
Condition(s):Head and Neck CancerLast Updated:June 11, 2010Terminated
Condition(s):Anaplastic Thyroid CancerLast Updated:June 9, 2014Terminated
Condition(s):Leukemia, Myelogenous, Acute; Myelodysplastic SyndromesLast Updated:August 8, 2017Terminated
Condition(s):Neuroendocrine TumorsLast Updated:April 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.